-
Abstract Number: 1516
Diagnostic Performance of Anti-ribosomal P Antibodies in Cerebrospinal Fluid of Neuropsychiatric Systemic Lupus Erythematosus with Diffuse Central Nervous System Manifestations. Experience in a Tertiary Center in Mexico
-
Abstract Number: 1517
Diagnostic Performance of Anti-dsDNA Antibodies in Pleural, Ascitic and Pericardial Fluid for Lupus Serositis: Experience of a Tertiary Center in Mexico
-
Abstract Number: 1518
Predictive Value of Chronic Histologic Changes in Lupus Nephritis
-
Abstract Number: 1519
Incidence, Risk Factors, and Outcomes of Severe Lymphopenia in Systemic Lupus Erythematosus
-
Abstract Number: 1520
The Influence of Trauma on Features of Type 2 SLE
-
Abstract Number: 1521
Contemporary Lupus Nephritis Treatment and Outcomes Among Patients with Systemic Lupus Erythematosus in the United States
-
Abstract Number: 1522
Impact of Thrombocytopenia on In-hospital Mortality and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus: An Analysis of the National Inpatient Sample Database 2020
-
Abstract Number: 1523
Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020
-
Abstract Number: 1524
Thrombocytopenia and Systemic Lupus Erythematosus: A Meta-analysis of Observational Studies
-
Abstract Number: 1525
Early versus Late Lupus Nephritis: A Meta-analysis of Observational Studies
-
Abstract Number: 1526
Utilizing Electronic Health Records to Identify Clinical Features of ANA-Positive Patients Imparting High Risk for Progression to Systemic Lupus Erythematosus
-
Abstract Number: 1527
Comparative Harms in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab or Belimumab: A Multicenter Cohort Study Using the TriNetX Research Network
-
Abstract Number: 1528
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: National Inpatient Sample Analysis
-
Abstract Number: 1529
Systemic Lupus Erythematous and Neuromyelitis Optica Overlap and Risk of Infection in Hospitalized Patients
-
Abstract Number: 1530
Belimumab-Treated Patients with Systemic Lupus Erythematosus Without Prior Immunosuppressant Use Have More Favorable Clinical Outcomes Than Those with Prior Use of an Immunosuppressant
- « Previous Page
- 1
- …
- 101
- 102
- 103
- 104
- 105
- …
- 181
- Next Page »